Skip to content

To evaluate the efficacy and safety of endoscopic surgical system assisted laparoscopic colorectal cancer resection in clinical trials

To evaluate the efficacy and safety of endoscopic surgical system assisted laparoscopic colorectal cancer resection in clinical trials

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063172
Enrollment
Unknown
Registered
2022-09-01
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients clinically diagnosed with colorectal tumors requiring colorectal resection; 2. Imaging examination showed no extensive invasion or distant metastasis of the tumor; 3. Aged 18-80 years, no gender limit; 4. Able to cooperate with and complete follow-up and relevant examinations; 5. Voluntarily participate in this experiment and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with familial adenomatous polyposis and ulcerative colitis cancer; 2. Patients involving surrounding organs requiring combined organ excision, CRM(+) of rectal cancer, and RO excision is not expected; 3. Patients with cardiovascular and cerebrovascular diseases, blood system diseases and diabetes who cannot be controlled and cannot meet surgical standards; 4. Patients with immune system diseases that cannot be controlled and cannot meet surgical standards; 5. Severely obese patients with BMI > 30 kg/m^2; 6. Patients with intestinal obstruction, bleeding or perforation requiring emergency operation; 7. Patients who cannot tolerate anesthesia and laparoscopic surgery; 8. Pregnant or lactating patients; 9. ASA score is higher than Grade II; 10. Participating in other investigational drug or device clinical trials that have not been completed.

Design outcomes

Primary

MeasureTime frame
Successful operation;

Secondary

MeasureTime frame
Time of first postoperative anal exhaust;Surgeon satisfaction;

Countries

China

Contacts

Public ContactXiao Yi
xiaoy@pumch.cn+86 10 69152212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026